ArticleGynecologic oncology2011
Late GI and bladder toxicities after radiation for uterine cancer.
Article in Gynecologic oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
- Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).La Radiologia medica · 2024Guideline
- Functional Changes of the Genitourinary and Gastrointestinal Systems before and after the Treatment of Endometrial Cancer-A Systematic Review.Journal of clinical medicine · 2021Review
- Gastrointestinal consequences of cancer treatment: evaluation of 10 years' experience at a tertiary UK centre.Frontline gastroenterology · 2021Article
- Long-term Somatic Disease Risk in Adult Danish Cancer Survivors.JAMA oncology · 2019Article
- Acute radiation impacts contractility of guinea-pig bladder strips affecting mucosal-detrusor interactions.PloS one · 2018Article
- Do comorbidity influences acute toxicity and outcome in elderly patients with endometrial cancer treated by adjuvant radiotherapy plus brachytherapy?Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2013Article
- The effect of postoperative beam, implant, and combination radiation therapy on GI and bladder toxicities in female Medicare beneficiaries with stage I uterine cancer.Journal of geriatric oncology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveTo determine the impact of radiation treatment for corpus uteri cancer on the development of late gastrointestinal (GI) and bladder toxicities in older women.
methodsWe used a linked database of the Surveillance, Epidemiology and End Results (SEER) program tumor registry records and Medicare claims to estimate the risk of late radiation toxicities in a population based sample of 23,591 women diagnosed with corpus uteri cancer from 1992 to 2005. Gastrointestinal (GI) and bladder diagnoses were included up to 60 months after diagnosis. Cox proportional hazard models were used to estimate risk of any late GI or bladder diagnosis with or without hospitalization, due to radiation.
resultsWomen treated with radiation had an absolute increase in late GI toxicities of 7.7% and an absolute increase in late bladder toxicities of 3.9%. Most toxicities were not severe. Only 10% of irradiated women with a lower GI diagnosis and less than 1% of irradiated women with a bladder diagnosis, required hospitalization. In the multivariable analysis, advancing age, having chemotherapy, higher comorbidities and prior or early GI and bladder diagnoses were predictive of late toxicities among irradiated women.
conclusionsLate GI toxicities are more common than previously reported. It is important to analyze late toxicities in population based samples of women with uterine cancer. The results of this and future analyses can be used to identify areas where development of "survivorship plans" will remind and encourage women to report symptoms related to potential toxicities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.